1. Home
  2. GFAI vs PASG Comparison

GFAI vs PASG Comparison

Compare GFAI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • PASG
  • Stock Information
  • Founded
  • GFAI 2018
  • PASG 2017
  • Country
  • GFAI Singapore
  • PASG United States
  • Employees
  • GFAI N/A
  • PASG N/A
  • Industry
  • GFAI Diversified Commercial Services
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • PASG Health Care
  • Exchange
  • GFAI Nasdaq
  • PASG Nasdaq
  • Market Cap
  • GFAI 23.3M
  • PASG 20.3M
  • IPO Year
  • GFAI N/A
  • PASG 2020
  • Fundamental
  • Price
  • GFAI $1.11
  • PASG $5.74
  • Analyst Decision
  • GFAI Strong Buy
  • PASG Strong Buy
  • Analyst Count
  • GFAI 1
  • PASG 3
  • Target Price
  • GFAI $4.50
  • PASG $153.33
  • AVG Volume (30 Days)
  • GFAI 721.9K
  • PASG 106.5K
  • Earning Date
  • GFAI 09-23-2025
  • PASG 08-11-2025
  • Dividend Yield
  • GFAI N/A
  • PASG N/A
  • EPS Growth
  • GFAI N/A
  • PASG N/A
  • EPS
  • GFAI N/A
  • PASG N/A
  • Revenue
  • GFAI $36,347,373.00
  • PASG N/A
  • Revenue This Year
  • GFAI $5.66
  • PASG N/A
  • Revenue Next Year
  • GFAI $4.69
  • PASG N/A
  • P/E Ratio
  • GFAI N/A
  • PASG N/A
  • Revenue Growth
  • GFAI 0.18
  • PASG N/A
  • 52 Week Low
  • GFAI $0.76
  • PASG $5.12
  • 52 Week High
  • GFAI $3.88
  • PASG $26.60
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 39.64
  • PASG 42.61
  • Support Level
  • GFAI $1.27
  • PASG $5.12
  • Resistance Level
  • GFAI $1.48
  • PASG $7.70
  • Average True Range (ATR)
  • GFAI 0.11
  • PASG 0.75
  • MACD
  • GFAI -0.03
  • PASG 0.01
  • Stochastic Oscillator
  • GFAI 7.14
  • PASG 23.91

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: